Insider · CIK 0001739693

Chondros Dimitrios

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001739693

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-08-03	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, Chief Medical Officer	SSale	−1,328 sh	$16.70	−$22.2K	38,584
2019-06-01	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, Chief Medical Officer	MExercise/Conversion	+2,043 sh	—	—	40,618
2019-06-01	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, Chief Medical Officer	FTax Payment	−706 sh	$14.75	−$10.4K	39,912
2019-06-01	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Medical Officer	MExercise/Conversion	−2,043 sh	—	—	4,084
2019-02-22	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, Chief Medical Officer	MExercise/Conversion	+3,884 sh	—	—	39,918
2019-02-22	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, Chief Medical Officer	FTax Payment	−1,343 sh	$16.81	−$22.6K	38,575
2019-02-22	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Medical Officer	MExercise/Conversion	−3,884 sh	—	—	7,767
2019-02-14	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, Chief Medical Officer	MExercise/Conversion	+6,790 sh	—	—	38,389
2019-02-14	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, Chief Medical Officer	FTax Payment	−2,322 sh	$16.54	−$38.4K	36,067
2019-02-14	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Medical Officer	MExercise/Conversion	−6,790 sh	—	—	20,370
2019-02-12	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	SVP, Chief Medical Officer	AAward	+71.6K sh	—	—	71,602
2019-02-12	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsA Award	SVP, Chief Medical Officer	AAward	+37.5K sh	—	—	37,538
2019-02-03	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, Chief Medical Officer	FTax Payment	−2,503 sh	$16.12	−$40.3K	31,599
2019-02-03	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, Chief Medical Officer	SSale	−2,536 sh	$16.41	−$41.6K	31,566
2018-08-03	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, Chief Medical Officer	FTax Payment	−1,305 sh	$17.08	−$22.3K	34,102
2018-06-01	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, Chief Medical Officer	MExercise/Conversion	+2,043 sh	—	—	36,119
2018-06-01	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, Chief Medical Officer	FTax Payment	−712 sh	$18.59	−$13.2K	35,407
2018-06-01	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Medical Officer	MExercise/Conversion	−2,043 sh	—	—	6,127

Recent filings

Accepted (ET)
Aug 54
Chondros Dimitrios0001179110-19-009165
SEC(opens sec.gov)
Jun 34
Chondros Dimitrios0001179110-19-007033
SEC(opens sec.gov)
Feb 224
Chondros Dimitrios0001179110-19-002465
SEC(opens sec.gov)
Feb 204/A
Chondros Dimitrios0001179110-19-002193
SEC(opens sec.gov)
Feb 154
Chondros Dimitrios0001179110-19-002007
SEC(opens sec.gov)
Feb 144
Chondros Dimitrios0001179110-19-001934
SEC(opens sec.gov)
Feb 54
Chondros Dimitrios0001179110-19-001321
SEC(opens sec.gov)
Aug 64
Chondros Dimitrios0001179110-18-010332
SEC(opens sec.gov)
Jun 54
Chondros Dimitrios0001179110-18-008049
SEC(opens sec.gov)

Companies

HALOZYME THERAPEUTICS, INC.SVP, Chief Medical OfficerHALO

Address

C/O HALOZYME THERAPEUTICS, INC. 11388 SORRENTO VALLEY ROAD

SAN DIEGO, CA, 92121